Logo

Morepen Laboratories Ltd. Share Price

Pharmaceuticals & Drugs

Morepen Laboratories Ltd. (INR)67.372.6   (4%)

Exchange ScripsBSE500288NSEMOREPENLABISININE083A01026

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Morepen Laboratories Ltd. Performance

Market performance

Open price65
High68.12
Volumes10878246
Prev Close67.37
Low64.83
Closing date2025-06-11

Historical performance

1 Year High100.90
3 Year High100.90
5 Year High100.90
1 Year Low42.00
3 Year Low23.60
5 Year Low19.05

Morepen Laboratories Ltd. Fundamentals

Company Valuation

Market Cap
Market Cap (₹Cr)
NaN
Face Value
Face Value (₹)
P/E Ratio
P/E Ratio
Dividend Yield
Dividend Yield
N/A

Morepen Laboratories Ltd. Investment Returns

1 Year
36.7%
3 Years
71%
5 Years
220%
10 Years
488.4%

Morepen Laboratories Ltd. Technicals

IndicatorsValueSignal
5-DMA65.18Bullish
10-DMA65.02Bullish
20-DMA64.86Bullish
50-DMA58.94Bullish
100-DMA57.15Bullish
200-DMA69.72Bearish

Shareholding Pattern

FieldMar-2025Dec-2024Sep-2024Jun-2024Mar-2024
Promoters3535353535
Foreign Investors---------------
Domestic Investors3535353535
Public Investors468825448326430894348731335984
Government11111

Morepen Laboratories Ltd. Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income14061201121
Operating Profit172685715681306
Interest37202418
Depreciation335279276303
Profit Before Tax13545581267985
Consolidated Net Profit9623871017971
Adjusted EPS2122

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital10221022956900
Total Reserves7450650745682910
Minority Interest----5-5-5
Total Non-Current Liabilities439369355301
Total Liabilities1293211105107008581
Capital Work in Progress24517014120
Total Assets1293211105107008581

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities734-912-602508
Cash Flow from Investing Activities-833-465-317-704
Cash Flow from Financing Activitie521435663473
Net Cash Inflow / Outflow-4759-256277
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 35.81.
  • 3Y Stock Price CAGR of the stock is 20.5.
  • The stock has a beta of 1.8.
  • In the last financial year, the company had an EBITDA of ₹1726 Million.
  • The company generated revenue of ₹16904 Million in the previous financial year.

Morepen Laboratories Ltd.

67.372.6   (4%)

Investment Amount: ₹ 1000000
Current Value: ₹ 1283727.1
No. of Shares: 19054.9
Performance:28.4%
P/L: ₹283727.1

Top Gainers

SymbolChange%
GTL11.18(20%)
KARMAENG69.55(20%)
ENERGYDEV26.53(20%)
GTLINFRA1.81(20%)
ANTGRAPHIC1.51(20%)

Top Losers

SymbolChange%
WEALTH1251.95(-9%)
IEX193.68(-8%)
HARSHA397.95(-8%)
PILITA17.91(-7%)
UNITDSPR1503.8(-7%)
SRPL0.6(-6%)
MBAPL342.9(-6%)
PREMIERPOL50.91(-6%)

Similar stocks

Suven Life Sciences Ltd.

73.4

247.02

May 11 - June 11

Ind-Swift Laboratories Ltd.

56.9

110.27

May 11 - June 11

Dishman Carbogen Amcis Ltd.

55.9

288.6

May 11 - June 11

Venus Remedies Ltd.

54.1

461.25

May 11 - June 11

Shilpa Medicare Ltd.

52.7

975.3

May 11 - June 11

Wockhardt Ltd.

49.6

1831.1

May 11 - June 11

IOL Chemicals And Pharmaceuticals Ltd.

49.2

92.81

May 11 - June 11

Syncom Formulations (India) Ltd.

46.7

22.15

May 11 - June 11

Announcing Stock of the Month!

Stock of the Month
Stock of the Month